financetom
Business
financetom
/
Business
/
Elbit Systems Q2 Non-GAAP Earnings, Revenue Increase; Dividend Raised -- Shares up Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Elbit Systems Q2 Non-GAAP Earnings, Revenue Increase; Dividend Raised -- Shares up Pre-Bell
Aug 13, 2025 1:50 AM

04:30 AM EDT, 08/13/2025 (MT Newswires) -- Elbit Systems ( ESLT ) reported Q2 non-GAAP earnings Wednesday of $3.23 per diluted share, up from $2.08 a year earlier.

One analyst polled by FactSet expected $2.56.

Revenue for the quarter that ended June 30 was $1.97 billion, up from $1.63 billion a year earlier.

One analyst surveyed by FactSet expected $1.89 billion.

Outlining the impact of recent conflicts in the Middle East, Israel-based Elbit ( ESLT ) said increased demand from the country's defense ministry "may continue and could generate material additional orders." It said the orders backlog as of June 30 totaled $23.8 billion, with 68% attributable to customers outside Israel.

Elbit's ( ESLT ) board declared a dividend of $0.75 per share, up from its prior dividend of $0.60 and payable Oct. 27 to holders of record Oct. 14.

The company's shares were up 6.7% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google limits on access to Android Auto may breach EU rules, court adviser says
Google limits on access to Android Auto may breach EU rules, court adviser says
Sep 5, 2024
BRUSSELS, Sept 5 (Reuters) - An adviser to Europe's top court on Thursday sided with Italy's antitrust authority, saying Alphabet unit Google's refusal to allow an e-mobility app developed by Enel access to its Android Auto platform may breach competition rules. Google's refusal to provide third-party access to Android Auto platform may be in breach of competition rules, Advocate General...
Royalty Pharma, Ascendis Pharma Unit Have $150 Million Royalty Funding Agreement
Royalty Pharma, Ascendis Pharma Unit Have $150 Million Royalty Funding Agreement
Sep 5, 2024
05:49 PM EDT, 09/03/2024 (MT Newswires) -- Royalty Pharma plc ( RPRX ) entered into a $150 million capped synthetic royalty funding agreement with an Ascendis Pharma ( ASND ) unit. The Ascendis Pharma Bone Diseases subsidiary will get an upfront payment of $150 million in exchange for a 3% royalty on US net sales of Yorvipath, a hormone replacement...
Jfrog Insider Sold Shares Worth $314,464, According to a Recent SEC Filing
Jfrog Insider Sold Shares Worth $314,464, According to a Recent SEC Filing
Sep 5, 2024
05:57 PM EDT, 09/03/2024 (MT Newswires) -- Tali Notman, Chief Revenue Officer, on September 03, 2024, sold 11,621 shares in Jfrog ( FROG ) for $314,464. Following the Form 4 filing with the SEC, Notman has control over a total of 547,413 shares of the company, with 547,413 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1800667/000141588924022707/xslF345X05/form4-09032024_090957.xml Price: 26.97, Change: +0.63, Percent Change:...
UK regulator finds no suicidal thoughts link to diabetes, obesity drugs
UK regulator finds no suicidal thoughts link to diabetes, obesity drugs
Sep 5, 2024
LONDON, Sept 4 (Reuters) - Britain's health regulator said on Wednesday that the available data does not establish a link between a popular class of diabetes and obesity drugs, including Novo Nordisk's Wegovy, and suicidal thoughts. The Medicines and Healthcare products Regulatory Agency (MHRA) began a review of safety data for the class of drugs, known as GLP-1 receptor agonists,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved